We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
-3.24%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+305.76%
AUM
$73.5B
AUM Growth
-$7.73B
(-9.5%)
Cap. Flow
-$10.4B
Cap. Flow
% of AUM
-14.12%
Top 10 Holdings %
Top 10 Hldgs %
24.14%
Holding
2,549
New
227
Increased
861
Reduced
712
Closed
243
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$301M |
| 2 |
Estee Lauder
EL
|
+$252M |
| 3 |
Boeing
BA
|
+$251M |
| 4 |
Kenvue
KVUE
|
+$174M |
| 5 |
Fidelity National Information Services
FIS
|
+$166M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$547M |
| 2 |
Union Pacific
UNP
|
+$459M |
| 3 |
Pinnacle West Capital
PNW
|
+$203M |
| 4 |
Wells Fargo
WFC
|
+$199M |
| 5 |
Bank of America
BAC
|
+$199M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.75% |
| 2 | Healthcare | 13.74% |
| 3 | Financials | 13.36% |
| 4 | Industrials | 11.58% |
| 5 | Consumer Discretionary | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVRO
626
DELISTED
NEVRO CORP.
NVRO
| $3.05M | ﹤0.01% |
158,642
+2,269
| +1% | +$48.4K |
|
627
Royce Value Trust
RVT
$2.27B
| $3.05M | ﹤0.01% |
236,857
-1,718
| -0.7% | -$23.5K |
|
|
ABCM
628
DELISTED
Abcam PLC
ABCM
| $2.97M | ﹤0.01% |
131,398
+43,851
| +50% | +$1.01M |
|
629
Cirrus Logic
CRUS
$6.19B
| $2.97M | ﹤0.01% |
40,125
-4,905
| -11% | -$383K |
|
630
Vanguard FTSE Developed Markets ETF
VEA
$234B
| $2.89M | ﹤0.01% |
66,057
+10,879
| +20% | +$498K |
|
631
iShares MSCI World ETF
URTH
$8.2B
| $2.85M | ﹤0.01% |
23,696
-668
| -3% | -$83.2K |
|
|
ALTR
632
DELISTED
Altair Engineering Inc
ALTR
| $2.84M | ﹤0.01% |
45,427
+45,400
| +168,148% | +$3.05M |
|
633
iShare MSCI Eurozone ETF
EZU
$9.84B
| $2.83M | ﹤0.01% |
67,136
-6,534
| -9% | -$293K |
|
634
iShares Expanded Tech-Software Sector ETF
IGV
$14.1B
| $2.83M | ﹤0.01% |
41,485
+14,275
| +52% | +$1M |
|
635
Alnylam Pharmaceuticals
ALNY
$28.9B
| $2.8M | ﹤0.01% |
15,831
+14,892
| +1,586% | +$2.84M |
|
636
A.O. Smith
AOS
$8.56B
| $2.79M | ﹤0.01% |
42,169
-2,307
| -5% | -$164K |
|
|
MRO
637
DELISTED
Marathon Oil Corporation
MRO
| $2.77M | ﹤0.01% |
103,556
+41,378
| +67% | +$1.07M |
|
638
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.9B
| – | – |
0
| – | – |
|
639
iShares Core Dividend Growth ETF
DGRO
$43.4B
| $2.74M | ﹤0.01% |
55,279
-5,200
| -9% | -$269K |
|
640
Dave & Buster's
PLAY
$351M
| $2.73M | ﹤0.01% |
73,653
-70,382
| -49% | -$2.87M |
|
641
AMN Healthcare
AMN
$1.19B
| $2.7M | ﹤0.01% |
31,742
-6,276
| -17% | -$595K |
|
642
T-Mobile US
TMUS
$193B
| $2.68M | ﹤0.01% |
19,126
+6,110
| +47% | +$846K |
|
643
Bank OZK
OZK
$5.63B
| $2.66M | ﹤0.01% |
71,900
+15,985
| +29% | +$648K |
|
644
Neogen
NEOG
$2.46B
| $2.64M | ﹤0.01% |
142,586
+893
| +0.6% | +$19.4K |
|
645
Timken Company
TKR
$8.92B
| $2.64M | ﹤0.01% |
35,922
-29,611
| -45% | -$2.4M |
|
646
Ross Stores
ROST
$81.6B
| $2.6M | ﹤0.01% |
23,034
+11,149
| +94% | +$1.28M |
|
647
10x Genomics
TXG
$5.79B
| $2.57M | ﹤0.01% |
62,311
-37,141
| -37% | -$1.93M |
|
648
Simpson Manufacturing
SSD
$7.96B
| $2.56M | ﹤0.01% |
17,120
+14,861
| +658% | +$2.26M |
|
649
Recursion Pharmaceuticals
RXRX
$1.7B
| $2.56M | ﹤0.01% |
335,024
-10,099
| -3% | -$101K |
|
650
Ulta Beauty
ULTA
$23.2B
| $2.56M | ﹤0.01% |
6,409
-525
| -8% | -$230K |
|
Similar funds
QCM
Lazard Asset Management's Q3 2023 Portfolio in Review
As of Q3 2023, Lazard Asset Management held 2,549 positions worth $73.5B, down 9.5% from $81.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Lazard Asset Management withdrew a net $10.4B in Q3 2023, closing 243 positions and reducing 712 holdings. Its most notable exit was Littelfuse, an estimated $24.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Lazard Asset Management opened a new position in ScottsMiracle-Gro worth $28.3M.
- Lazard Asset Management's largest Q3 2023 buy was ScottsMiracle-Gro: 548,310 shares worth $28.3M.
- Lazard Asset Management added most to PPL Corp in Q3 2023, an estimated $301M increase.
- Lazard Asset Management's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $547M.
- Lazard Asset Management fully exited Littelfuse in Q3 2023, selling an estimated $24.3M.
- Lazard Asset Management's ten largest holdings make up 24% of its $73.5B portfolio in Q3 2023.
- Lazard Asset Management opened 227 new positions and closed 243 in Q3 2023.
- Lazard Asset Management's portfolio value fell 9.5% quarter-over-quarter to $73.5B.
Based on Lazard Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.